<DOC>
	<DOCNO>NCT01885156</DOCNO>
	<brief_summary>To see well Naftin 1 % cream work apply daily affected area . The result compare use placebo cream , cream active ingredient . Safety also measure .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Naftin 1 % Cream Adolescent Subjects With Tinea Cruris</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Naftifine</mesh_term>
	<criteria>Review sign statement Informed Consent HIPAA authorization . Males nonpregnant female â‰¥ 12 year age 17 year , 11 month , race sex . Females childbearing potential must negative urine pregnancy test . The parent/legal guardian must complete informed consent process AND subject must complete assent process sign appropriate form ( age appropriate ) . Presence tinea cruris characterize clinical evidence tinea infection ( least moderate erythema , moderate scaling , mild pruritus ) base sign symptom . KOH positive baseline skin scraping obtain site severely affect representative site overall severity . Subjects must good health free clinically significant disease might interfere study evaluation . Subject must able understand requirement study willing comply study requirement . A life threaten condition ( ex . autoimmune deficiency syndrome , cancer , unstable angina , myocardial infarction ) within last 6 month . Subjects abnormal finding physical laboratory consider investigator clinically important indicative condition might complicate interpretation study result . Severe dermatophytoses , mucocutaneous candidiasis , bacterial skin infection . Subjects know hypersensitivity study medication component . Subjects recent history currently know abuse alcohol drug . Uncontrolled diabetes mellitus . Hemodialysis chronic ambulatory peritoneal dialysis therapy . Current diagnosis immunocompromising condition . Atopic contact dermatitis . Severe dermatophytoses , mucocutaneous candidiasis , bacterial skin infection . Female subject pregnant lactating , use agree use acceptable form contraception study , intend become pregnant study ( female surgically sterilize least 2 year consider childbearing potential ) . Subjects use follow medication : Topical antifungal therapy , powder topical corticosteroid apply within 14 day prior randomization . Terbinafine , butenafine , naftifine ( topical ) within 30 day prior randomization . Oral antifungal therapy within 3 month randomization ( 8 month oral terbinafine ) . Systemic antibiotic corticosteroid treatment within 30 day randomization . Any significant treatment , except hormonal contraception multivitamin , discretion investigator would interfere study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>